249 related articles for article (PubMed ID: 17951406)
1. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.
Wang HC; Huang W; Lai MD; Su IJ
Cancer Sci; 2006 Aug; 97(8):683-8. PubMed ID: 16863502
[TBL] [Abstract][Full Text] [Related]
4. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
5. Zinc-dependent interaction between JAB1 and pre-S2 mutant large surface antigen of hepatitis B virus and its implications for viral hepatocarcinogenesis.
Hsu JL; Chuang WJ; Su IJ; Gui WJ; Chang YY; Lee YP; Ai YL; Chuang DT; Huang W
J Virol; 2013 Dec; 87(23):12675-84. PubMed ID: 24049181
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
7. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M
Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460
[TBL] [Abstract][Full Text] [Related]
9. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
Wang LH; Huang W; Lai MD; Su IJ
Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.
Wang HC; Chang WT; Chang WW; Wu HC; Huang W; Lei HY; Lai MD; Fausto N; Su IJ
Hepatology; 2005 Apr; 41(4):761-70. PubMed ID: 15726643
[TBL] [Abstract][Full Text] [Related]
11. Interaction of LHBs with C53 promotes hepatocyte mitotic entry: A novel mechanism for HBV-induced hepatocellular carcinoma.
Lei Y; Liu H; Yang Y; Wang X; Ren N; Li B; Liu S; Cheng J; Fu X; Zhang J
Oncol Rep; 2012 Jan; 27(1):151-9. PubMed ID: 21971960
[TBL] [Abstract][Full Text] [Related]
12. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.
Su IJ; Wang HC; Wu HC; Huang WY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1169-74. PubMed ID: 18505413
[TBL] [Abstract][Full Text] [Related]
13. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
Supriatno ; Harada K; Yoshida H; Sato M
Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
[TBL] [Abstract][Full Text] [Related]
14. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I
Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262
[TBL] [Abstract][Full Text] [Related]
18. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
Qin J; Wang Z; Wang Y; Ma L; Ni Q; Ke J
Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
[TBL] [Abstract][Full Text] [Related]
19. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
[TBL] [Abstract][Full Text] [Related]
20. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX
Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]